Corrigendum to “Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo” [Biomed. Pharmacother. 116 (2019) 109032]

• Mao-Chi Weng,
• Ming-Hsin Li,
• Jing Gung Chung,
• Yu-Chang Liu,
• Wu Jeng-Yuan,
• Fei-Ting Hsu,
• Hsin-Ell Wang

Affiliations

Mao-Chi Weng

Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taiwan; Isotope Application Division, Institute of Nuclear Energy Research, Atomic Energy Council, Taiwan

Ming-Hsin Li

Isotope Application Division, Institute of Nuclear Energy Research, Atomic Energy Council, Taiwan

Jing Gung Chung

Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Department of Biotechnology, Asia University, Taichung, Taiwan

Yu-Chang Liu

Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan; Department of Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan; Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan

Wu Jeng-Yuan

Department of Thoracic Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan; Corresponding author at: Department of Thoracic Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan.

Fei-Ting Hsu

Department of Biological Science and Technology, China Medical University, Taichung, Taiwan; Corresponding author at: Department of Biological Science and Technology, China Medical University, Taichung, 404, Taiwan.

Hsin-Ell Wang

Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taiwan; Corresponding author at: Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, 112, Taiwan.